Abstract 1743: QLS1209, A highly potent and selective PKMYT1 inhibitor demonstrates activity in tumors with CCNE1Amp and/ or FBXW7LoF mutations
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yuxing Zhang, Jiasheng Fu, Rongyan Wang, Jianping Chen, Changliang He, Junguo Hao, Xinrui Shao, Ling Li, Hua Qin, Guangyue Lei, Ping Chen, Dong Yang, Xinghua Cheng, Qingmei Zheng, Zheng Wang, Guqin Shi, Wenyuan Qian, Daqing Sun, Weimei Sun, Weikang Tao
Institution: Qilu Pharmaceutical Co., Ltd. (China)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629191